Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023
Offer reference number: CM/PHR/22/5660
CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Abbvie Ltd | 08004972 | ~£264,003,228 estimated from lot values | LOBBYIST Policy Connect Limited (15 quarters) Portland PR Limited (3 quarters) WA Communications Ltd (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter) |
| Amgen Ltd | 02354269 | ~£264,003,228 estimated from lot values | - |
| Biogen | 06151086 | ~£264,003,228 estimated from lot values | - |
| Celltrion Healthcare United Kingdom Limited | 11685363 | ~£264,003,228 estimated from lot values | - |
| Fresenius Kabi Limited | 02182135 | ~£264,003,228 estimated from lot values | - |
| Sandoz Ltd | 01547204 | ~£264,003,228 estimated from lot values | - |
Government spending data: These suppliers have received £94,622,388 in 3,735 payments (over £25k) from NHS Supply Chain (DHSC-funded), Department of Health and Social Care, Guy's and St Thomas' NHS FT, University Hospitals Bristol and Weston NHS FT, Manchester University NHS Foundation Trust and 10 more public bodies (2010-08-03 to 2026-03-31).